EXUMA Biotechnology

  • Our Science Expand
      back
    • Tumor Metabolism Regulated CAR-T
    • Cell & Gene Therapy Delivery Systems
    • Analytics
  • Pipeline
  • Our Company Expand
      back
    • Strategic Relationships
    • Our Team
  • News & Resources Expand
      back
    • Blog Posts
    • Mentions
    • Posters
    • Presentations
    • Press Releases
  • Careers Expand
      back
    • Job Openings
  • Contact
Skip to content
October 4 2022October 20, 2022 by ICS Developers

Dr. Sid Kerkar speaks with CGT Live about how EXUMA’s TaNK platforms aim to make CAR therapy safer and faster through novel lentivector engineering

The Vice President of Research & Development, Oncology at Exuma Biotech discussed the company’s platforms, including CAR-TaNK cells.

Click here to read the full article

  • Jobs
  • Legal
    • LinkedIn
    • Twitter
  • ©2023 EXUMA Biotechnology